BioMarin Pharmaceutical Market Cap

BioMarin Pharmaceutical has a market cap or net worth of 210.01 billion as of July 18, 2025. Its market cap has decreased by -26.83% in one year.

Market Cap

210.01B

Enterprise Value

197.43B

Revenue

60.30B

Ranking

n/a

PE Ratio

19.61

Stock Price

1,100.00

Market Cap Chart

Since July 23, 1999, BioMarin Pharmaceutical's market cap has increased from 4.20B to 210.01B, an increase of 4,895.69%. That is a compound annual growth rate of 16.23%.

Market Cap History

Date	Market Cap	% Change
Jul 17, 2025	210.01B	-19.55%
Dec 31, 2024	261.03B	-14.99%
Dec 29, 2023	307.05B	-18.16%
Dec 30, 2022	375.17B	12.82%
Dec 31, 2021	332.53B	4.98%
Dec 31, 2020	316.75B	10.58%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Wal-Mart de México	1,000.83B
Grupo Financiero Banorte	459.28B
Arca Continental	323.21B
Industrias Peñoles	203.93B
GMéxico Transportes	140.89B
FIBRA Prologis	110.08B
Fibra UNO	100.38B
Promotora y Operadora de Infraestructura, S. A. B. de C. V.	95.43B

Market Cap Rankings